MiddleBrook Pharmaceuticals, Inc
www.middlebrookpharma.comMiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® – the first and only FDA-approved once-daily amoxicillin.
Read more
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® – the first and only FDA-approved once-daily amoxicillin.
Read more
Employees statistics
View all employeesPotential Decision Makers
Vice President , Managed Markets
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Director , Sales Force Operations
Email ****** @****.comPhone (***) ****-****Territory Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(7)
Reach decision makers at MiddleBrook Pharmaceuticals, Inc
Free credits every month!
MiddleBrook Pharmaceuticals, Inc FAQ
Pharmaceutical Manufacturing
We'll help you understand if Lusha can solve your business needs.
